Injection-Based Administration Subcutaneous injections: All GLP-1 RAs are administered via subcutaneous injection Prefilled pens: Most common delivery system, allows for self-administration Auto-injectors: Simplify the process for patients with dexterity issues Multi-dose pens: Require dose dialing and needle attachment Dosing frequency: Daily: Liraglutide (Saxenda, Victoza), some formulations of exenatide (Byetta) Weekly: Semaglutide (Wegovy, Ozempic), tirzepatide (Mounjaro, Zepbound), dulaglutide (Trulicity), exenatide extended-release (Bydureon) Titration schedules: Most FDA-approved GLP-1 RAs require gradual dose escalation to minimize gastrointestinal side effects
2 on the Billboard Hot 100
doi: 10.3389/fneur.2023.1103416 114 QuY.YanM.ZhangQ
While it also offers significant health benefits, L-Glutathione may not have the same level of clinical backing, efficiency, or bioavailability as Setria
Chronic heartburn and acid reflux
Animal studies have shown promising results, and initial human studies are underway